Skip to main content
. 2018 Jan 22;9:16. doi: 10.3389/fimmu.2018.00016

Table 2.

Characteristics of ANA-reactive mAbs derived from graft-versus-host disease (GVHD) mice.a,b

Mouse number Hybridoma number IgG isotype Ig-heavy chain v-region Ig-light chain v-region
GVHD # 1 1.12.1A IgG2b Vh8-8 D2-14 J4 Vk4-74 Jk2
1.28.1 IgG2a Vh1-26 D1-1 J1 Vk4-74 Jk2
1.308.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.356.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.741.1 IgG2a Vh1-55 D2-4 J3 Vk3-4 Jk1
1.802.1 IgG2b Vh1-26 D1-1 J1 Vk4-63 Jk5

GVHD # 2 2.24.0 IgG2a Vh1-52 D1-1 J1 Vk14-111 Jk5
2.53.8 IgG2b Vh14-2 D2-2 J2 Vk14-111 Jk1
2.58.2 IgG2b Vh14-2 D2-2 J2 Vk14-111 Jk1
2.70.8 IgG2a Vh14-4 D1-1 J3 Vk3-10 Jk1
2.80.9 IgG2a Vh14-4 D1-1 J3 Vk3-12 Jk1
2.152.9 IgG2a Vh1-52 D1-1 J1 Vk3-10 Jk1
2.300.2 IgG2b Vh1-55 D2-1 J2 Vk3-10 Jk5
2.344.3 IgG2a Vh1-52 D1-1 J1 Vk14-111 Jk5
2.374.1 IgG2a Vh1-26 D1-1 J1 Vk3-7 Jk1
2.382.2 IgG2a Vh14-4 D2-1 J3 Vk3-10 Jk1
2.388.2 IgG2a Vh1-31 D2-4 J4 Vk3-10 Jk2
2.394.1 IgG2a Vh14-4 D1-1 J3 Vk3-10 Jk1

GVHD # 3 3.55.1 IgG2a Vh1-26 D1-1 J3 Vk4-74 Jk2
3.69.1 IgG2b Vh1-26 D1-1 J3 Vk4-74 Jk2
3.71.1 IgG2a Vh1-26 D2-5 J1 Vk4-74 Jk2
3.77.1 IgG2a Vh1-26 D1-1 J3 Vk4-74 Jk2
3.152.1 IgG2b Vh1-26 D1-1 J3 Vk4-74 Jk2

GVHD # 4 63.3.1 IgG2b Vh1-55 D2-4 J2 Vk4-74 Jk2
165.2.1 IgG2a Vh8-12 D2-2 J1 Vk15-103 Jk5

GVHD # 5 14.11.A IgG2b Vh1-50 D1-1 J2 Vk1-117 Jk2
381.11.A IgG2b Vh1-54 J4 Vk14-111 Jk2
685.9.A IgG2b Vh1-59 D2-5 J3 Vk17-127 Jk5
724.3.A IgG1 Vh1-26 D1-1 J3 Vk4-91 Jk4
738.8.A IgG1 Vh1-26 D1-1 J3 Vk3-7 Jk1
762.5.A IgG2a Vh5-17 D1-2 J4 Vk?
810.4.A IgG1 Vh1-52 D2-12 J2 Vk3-10 Jk1
865.12.A IgG2b Vh1-72 D3-3 J2 Vk4-74 Jk5
1011.39.A IgG2b Vh1-53 D1-1 J2 Vk17-127 Jk5

aAll the mAbs converted into germline sequences are boxed in orange.

bAll the mAbs using Vh1-26 are boxed in yellow and those using Vk4-74 in red.